[1]韩丹 恽海峰 金逸纯 孙宏文.平溃灌肠剂对溃疡性结肠炎肠双歧杆菌黏附性及相关炎性细胞因子的影响[J].国际中医中药杂志,2019,41(9):969-975.[doi:10.3760/cma.j.issn.1673-4246.2019.09.013]
 Han Dan,Yun Haifeng,Jin Yichun,et al.Study on the bifidobacterial adhesion to the host tissue in ulcerative colitis and related serum inflammatory factors with Pingkui enema[J].,2019,41(9):969-975.[doi:10.3760/cma.j.issn.1673-4246.2019.09.013]
点击复制

平溃灌肠剂对溃疡性结肠炎肠双歧杆菌黏附性及相关炎性细胞因子的影响

参考文献/References:

[1] Cosnes J,Gower-Rousseau C,Seksik P,et al. Epidemiology and natural history of inflammatory bowel diseases[J]. Gastroenterology,2011,140(6):1785-1794. DOI:10.1053/j. gastro.2011.01.055.

[2] Shapiro JM,Zoega H,Shah SA,et al. Incidence of Crohn’s disease and ulcerative colitis in Rhode Island: report from the Ocean State Crohn’s and Colitis Area Registry[J]. Inflamm Bowel Dis,2016,22(6):1456-1461. DOI:10.1097/MIB. 0000000000000745.

[3] Magro F,Rodrigues A,Vieira AI,et al. Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts[J]. Inflamm Bowel Dis,2012,18(3): 573-583. DOI:10.1002/ibd.21815.

[4] 程丽敏. 溃结灵Ⅳ号保留灌肠对TNBS诱导UC大鼠血清中D-乳酸、DAO及结肠组织中SOD的影响[J]. 中医药学报, 2012,40(2):38-41. DOI:10.3969/j.issn.1002-2392.2012.02.013.

[5] 徐阳,李伟光,刘海峰,等. 三硝基苯磺酸诱导小鼠溃疡性结肠炎模型制备的技术改良[J]. 世界华人消化杂志,2012, 20(2):106-112.

[6] 张仁霞,傅永锦,梁基智,等. 小檗碱治疗大鼠免疫复合性溃疡性结肠炎及下调炎性细胞因子作用[J]. 临床医学工程, 2014,21(11):1406-1409. DOI:10.3969/j.issn.1674-4659.2014. 11.1406.

[7] Høivik ML,Moum B,Solberg IC,et al. Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study[J]. Gut,2013,62(3): 368-375. DOI:10.1136/gutjnl-2012-302311.

[8] 赵青春,施洪飞,沈洪. 中医药治疗溃疡性结肠炎免疫机制研究进展[C]//中国中西医结合学会. 第七届全国中西医结合营养学术会议论文资料汇编,舟山:2016.

[9] Turroni F,Serafini F,Mangifesta,M,et al. Expression of sortase-dependent Pili of Bifidobacterium bifidum PRL2010 in response to environmental gut conditions[J]. FEMS Microbiol Lett,2014,357(1):23-33. DOI:10.1111/1574-6968.12509.

[10] 王瑞锋,王雪. 白头翁汤的药理作用与临床应用[J]. 中医学报,2010,25(2):270-271.

[11] 吕兰薰. 三七蒲黄仙鹤草的新效用[J]. 陕西中医函授, 1992(3):1-3.

[12] 李晓东,张学彦,郑磊,等. 白细胞介素在溃疡性结肠炎中的作用[J]. 胃肠病学和肝病学杂志,2015,24(1):4-7.

[13] 赵旭东,张薇. 溃疡性结肠炎发病机制研究进展[J]. 现代医药卫生,2008,24(10):1501-1502. DOI:10.3969/j.issn.1009-5519. 2008.10.058.

[14] Fuss IJ,Heller F,Boirivant M,et al. Non-classical CD1d-restricted NK T cells that Produce IL-13 characterize an atypical Th2 response in ulcerative colitis[J]. J Clin Invest, 2004,113(10):1490-1497. DOI:10.1172/jci19836.

[15] Heller F,Florian P,Bojarski C,et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution[J]. Gastroenterology,2005,129(2):550-564. DOI:10.1016/j.gastro. 2005.05.002.

[16] Rivière A,Selak M,Lantin D,et al. Bifidobacteria and butyrate-Producing colon bacteria: importance and strategies for their stimulation in the human gut[J]. Front Microbiol,2016,7: 979. DOI:10.3389/fmicb.2016.00979.

[17] Hamer HM,De Preter V,Windey K,et al. Functional analysis of colonic bacterial metabolism: relevant to health? [J]. Liver Physiol,2012,302(1):G1-G9. DOI:10.1152/ajpgi.00048.2011.

[18] Ruiz L,Ruas-Madiedo P,Gueimonde M,et al. How do bifidobacteria counteract environmental challenges? Mechanisms involved and physiological consequences[J]. Genes Nutr,2011,6(3):307-318. DOI:10.1007/s12263-010- 0207-5.

[19] Vergnolle N. Protease inhibition as new therapeutic strategy for GI diseases[J]. Gut,2016,65(7):1215-1224. DOI:10.1136/ gutjnl-2015-309147.

[20] Carroll IM, Maharshak N. Enteric bacterial proteases in inflammatory bowel disease-pathophysiology and clinical implications[J]. World J Gastroenterol,2013,19(43):7531-7543. DOI:10.3748/wjg.v19.i43.7531.

相似文献/References:

[1]袁援.薏苡附子败酱散保留灌肠结合柳氮磺胺吡啶治疗溃疡性结肠炎临床研究[J].国际中医中药杂志,2017,39(03):221.[doi:10.3760/cma.j.issn.1673-4246.2017.03.009]
 Yuan Yuan..Clinical study of enema aplication of Yiyi-Fuzi-Baijiang powder combined with oral sulfasalazine in treating ulcerative colitis [J].,2017,39(9):221.[doi:10.3760/cma.j.issn.1673-4246.2017.03.009]
[2]王晓宏 张邑.槐花散联合仙方活命饮治疗溃疡性结肠炎临床研究[J].国际中医中药杂志,2017,39(08):701.[doi:10.3760/cma.j.issn.1673-4246.2017.08.008]
 Wang Xiaohong*,Zhang Yi..Clinical study on the clinical effect of Sophora powder combined with Xianfang-Huoming decoction for ulcerative colitis [J].,2017,39(9):701.[doi:10.3760/cma.j.issn.1673-4246.2017.08.008]
[3]秦凯健 崔灿 黄信松 梁榕钰 娄铁铮 吴炯.葛根芩连汤加减方治疗溃疡性结肠炎的meta分析[J].国际中医中药杂志,2019,41(1):99.[doi:10.3760/cma.j.issn.1673-4246.2019.01.025]
 Qin Kaijian,Cui Can,Huang Xinsong,et al.A meta-analysis of Gegen-Qinlian decoction for ulcerative colitis [J].,2019,41(9):99.[doi:10.3760/cma.j.issn.1673-4246.2019.01.025]
[4]张钧芳 耿蕊.益气解毒汤结合美沙拉秦缓释颗粒治疗溃疡性结肠炎临床研究[J].国际中医中药杂志,2019,41(8):832.[doi:10.3760/cma.j.issn.1673-4246.2019.08.010]
 Zhang Junfang,Geng Rui.Clinical study of Yiqi-Jiedu decoction combined with mesalazine sustained release granules for the patients with ulcerative colitis[J].,2019,41(9):832.[doi:10.3760/cma.j.issn.1673-4246.2019.08.010]
[5]胡亚莉 沈舒文.沈舒文辨治溃疡性结肠炎经验[J].国际中医中药杂志,2019,41(10):1115.[doi:10.3760/cma.j.issn.1673-4246.2019.10.018]

备注/Memo

通信作者:孙宏文,Email: shw8101@163.com,电话:13912605516

基金项目:苏州市科技局民生科技-医疗卫生应用基础研究[第五项](SYSD2016192);国家中医药管理局吴门医派杂病流派传承工作室项目([2012]228)

更新日期/Last Update:

2019-09-03